Zacks Investment Management Staar Surgical CO Transaction History

Zacks Investment Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$46.82 - $76.2 $2,528 - $4,114	54 Added 0.45%	12,087 $586,000
Q3 2022 Nov 14, 2022	BUY	$70.55 - $111.58 $340,685 - $538,819	4,829 Added 67.03%	12,033 $849,000
Q2 2022 Aug 15, 2022	BUY	$50.24 - $80.48 $361,928 - $579,777	7,204 New	7,204 $511,000
Q4 2019 Feb 14, 2020	SELL	$24.55 - $38.13 $300,516 - $466,749	-12,241 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$25.78 - $34.8 $219,001 - $295,626	-8,495 Reduced 40.97%	12,241 $316,000
Q1 2019 May 15, 2019	SELL	$27.81 - $40.78 $606,313 - $889,085	-21,802 Reduced 51.25%	20,736 $709,000
Q4 2018 Feb 14, 2019	BUY	$28.91 - $50.0 $1.08 Million - $1.87 Million	37,423 Added 731.63%	42,538 $1.36 Million
Q3 2018 Nov 14, 2018	BUY	$30.85 - $50.65 $157,797 - $259,074	5,115 New	5,115 $246,000

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.28B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.